Funded Tech Companies
Goldenrod Therapeutics
Goldenrod Therapeutics, operating out of Houston, received equity investments from Ataxia Ventures, private investors and Fannin.
Company Overview
Company Name
Goldenrod Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3900 Essex Ln 575
Houston, TX 77027
USA
Houston, TX 77027
USA
Phone
Website
Email Address
Company Background Information
Overview
Goldenrod Therapeutics is a biotechnology company developing next-generation, brain-penetrant phosphodiesterase 4 (PDE4) inhibitors for serious neurological disorders. The company focuses on overcoming historical tolerability limitations of earlier PDE4 inhibitors while achieving robust central nervous system exposure. Through disciplined translational development, Goldenrod advances its lead program toward clinical evaluation with the goal of delivering differentiated therapies for patients with significant unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/8/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dev Chatterjee
Chief Financial Officer
Mark Worscheh
President
Atul Varadhachary
Vice President
Ross Clary
VP - R & D
Brian Wipke
Company Investors
- Ataxia Ventures
- Fannin
Browse more funded tech companies:
GoldenKey | Goldenset Collective
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs